Estrogen Replacement Therapy: In Response
نویسندگان
چکیده
منابع مشابه
Estrogen replacement therapy in breast cancer survivors.
OBJECTIVE To determine whether estrogen replacement therapy (ERT) adversely affected outcome of breast cancer survivors. METHOD A prospective descriptive study of all breast cancer survivors who requested ERT because of intractable menopausal symptoms. All patients presented voluntarily as gynecological outpatients and were all given oral continuous opposed ERT: 20 premarin and medroxyprogest...
متن کاملFocus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
Walsh • Focus on cardiovascular health C disease is the leading cause of death in the United States today. Fully 52% of women will die of cardiovascular disease, far exceeding the percentage who will die of all cancers combined, and far in excess of the 4% who will die of breast cancer.1 It has been known since the initial findings of the Framingham Study, however, that women have a 20-year adv...
متن کاملEstrogen and Progesterone Replacement Therapy Prevent Methamphetamine-Induced Synaptic Plasticity Impairment in Ovariectomized Rats
Background: Methamphetamine (METH) is one of the most popular psychostimulants which produce long lasting learning and memory impairment. Previous studies have indicated that estrogen and progesterone replacement therapy attenuate cognitive impairment against a wide array of neurodegenerative diseases. Present study was designed to figure out the effects of estrogen, progesterone alone or in co...
متن کاملEstrogen replacement therapy, atherosclerosis, and vascular function.
There is strong evidence from both human and nonhuman primate studies supporting the conclusion that estrogen deficiency increases the progression of atherosclerosis. More controversial is the conclusion that postmenopausal estrogen replacement inhibits the progression of atherosclerosis. Estrogen treatment of older women (>65 years) with pre-existing coronary artery atherosclerosis had no bene...
متن کاملEstrogen-progestin replacement therapy and endometrial cancer.
BACKGROUND It has been known for more than 20 years that estrogen replacement therapy substantially increases a woman's risk of developing endometrial cancer. To reduce this increased risk, progestins have been added to estrogen replacement therapy for between 5 and 15 days (usually 7 or 10 days) per "month" in a sequential fashion (sequential estrogen-progestin replacement therapy) or with eac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Mayo Clinic Proceedings
سال: 1996
ISSN: 0025-6196
DOI: 10.4065/71.2.212-b